Printer Friendly

Articles from Stem Cell Lab World (April 29, 2019)

1-13 out of 13 article(s)
Title Author Type Words
BioTime To Present Data From Dry AMD Study At ARVO. Clinical report 360
Cytori Divests "Cell Therapy Assets" For $7M. 825
FDA Gives Nod To Rolling Review Of Company's License Application For GvHD Therapy. 221
First Patient Enrolled In Japan In Study Of Treatment For ARDS. 405
First Subjects Dosed In Phase 1 Trial Of Stem Cell Mobilization Factor. 426
Hemostemix Announces Convertible Debenture Financing. 112
ISCO Completes Enrollment, Dosing In Parkinson's Trial. 424
Korean Firm To Develop Stem Cell-Based Atopic Dermatitis Drug With Kangstem Biotech. 141
Magenta To Present Preclinical Data From Stem Cell Gene Therapy Expansion Program. 324
Osiris Acquisition By Smith & Nephew Plc Closes. 221
Stacey Ma Joins Sana As EVP Technical. 108
ThermoGenesis Releases Enhanced X-MINI CD3 Selection Kit For Researchers. 250
Updated Phase 2a Results For First Stem Cell Trial In ACLF. 399

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters